Julie Smith

Companies

• Stoke Therapeutics, Inc.Board member Jun 5, 2020 to now¹
• ExelixisBoard member Sep 26, 2016 to now²
• Audentes Therapeutics, Inc.Board member Dec 13, 2016 to Jan 15, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Exelixis EXEL28,957 shares⁴$1.8M at $62.59May 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 27, 2026Granted 8,367 shares of Exelixis⁴
• Feb 18, 2026Sold 20,030 shares at $44.30 of Exelixis⁵
• Feb 18, 2026Exercised options 20,030 shares at $21.69 of Exelixis⁵
• Feb 18, 2026Sold 44,087 shares at $44.50 of Exelixis⁵
• Feb 18, 2026Exercised options 44,087 shares at $19.39 of Exelixis⁵
• Feb 17, 2026Sold 42,422 shares at $43.33 of Exelixis⁵
• Feb 17, 2026Exercised options 42,422 shares at $18.19 of Exelixis⁵
• May 29, 2025Granted 9,812 shares of Exelixis⁶
• Feb 28, 2025Sold 19,294 shares at $37.62 of Exelixis⁷
• Feb 28, 2025Exercised options 19,294 shares at $19.77 of Exelixis⁷
• Feb 27, 2025Sold 54,514 shares at $38.13 of Exelixis⁷
• Feb 27, 2025Exercised options 23,347 shares at $19.77 of Exelixis⁷
• Feb 27, 2025Exercised options 31,167 shares at $20.50 of Exelixis⁷
• Aug 13, 2024Other 4,682 shares of Exelixis⁸
• May 31, 2024Granted 10,015 shares of Exelixis⁹
• May 21, 2024Sold 27,280 shares at $21.12 of Exelixis¹⁰